We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.45% | 9.95 | 9.50 | 10.40 | 1,065,155 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -7.18 | 59.55M |
TIDMETX
RNS Number : 0526H
e-Therapeutics plc
02 June 2017
For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ---------------------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or E Therapeutics Plc the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ----------------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------ -------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ -------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ -------------------------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------ -------------------------------------------------- Other (please specify): --------------------------------------------------------- ------- -------------------------------------------------- 3. Full name of person(s) Richard Griffiths and controlled subject to the undertakings notification obligation: (iii) ----------------------------------------------------------- --------------------------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- --------------------------------------------------------- 5. Date of the transaction 1 June 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- --------------------------------------------------------- 6. Date on which issuer 2 June 2017 notified: ----------------------------------------------------------- --------------------------------------------------------- 7. Threshold(s) that is/are > 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20% crossed or reached: (vi, vii) ----------------------------------------------------------- --------------------------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- --------------- ------------- --------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ------------- ------------- ------------ ------------ ----------- Ordinary GB00B2823H99 < 3% < 3% 54,000,000 54,000,000 20.12% ------------- --------------- --------------- ------------- ------------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------ ----------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- --------------- ----------------------------- ----------------------- Nominal Delta --------------- ------------- ------------- --------------- ----------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 54,000,000 20.12% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------- Oak Trust Limited 1,500,000 Richard Griffiths 52,500,000 Total 54,000,000 ----------- The above entities are controlled by Richard Griffiths Proxy Voting: ------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ---------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ---------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ---------------- 13. Additional information: ------------------------------------------------------------- ---------------- 14. Contact name: James Sutcliffe ------------------------------------------------------------- ---------------- 15. Contact telephone number: +44 1534 719761 ------------------------------------------------------------- ---------------- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation -------------------------------------------------------- Full name (including legal form of legal entities) ------------------------------------------------------ Contact address (registered office for legal entities) ------------------------------------------------------ Phone number & email ------------------------------------------------------ Other useful information (at least legal representative for legal persons) ------------------------------------------------------ B: Identity of the notifier, if applicable -------------------------------------------------------- Full name
------------------------------------------------------ Contact address ------------------------------------------------------ Phone number & email ------------------------------------------------------ Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------------------------ C: Additional information -------------------------------------------------------- For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFSVRDIFIID
(END) Dow Jones Newswires
June 02, 2017 09:51 ET (13:51 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions